Geo Capital Gestora de Recursos’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,643
Closed -$307K 37
2024
Q2
$307K Sell
11,643
-79,228
-87% -$2.2M 0.31% 23
2024
Q1
$2.76M Buy
90,871
+2,618
+3% +$77.2K 3.12% 12
2023
Q4
$2.48M Sell
88,253
-46,826
-35% -$1.29M 2.85% 14
2023
Q3
$3.67M Buy
135,079
+4,592
+4% +$136K 3.39% 13
2023
Q2
$4.01M Sell
130,487
-12,261
-9% -$415K 3.11% 10
2023
Q1
$5.14M Buy
142,748
+18,658
+15% +$692K 3.81% 10
2022
Q4
$4.9M Sell
124,090
-13,116
-10% -$547K 3.92% 10
2022
Q3
$5.51M Sell
137,206
-12,183
-8% -$520K 4.35% 11
2022
Q2
$6.28M Sell
149,389
-51,303
-26% -$2.1M 4.24% 13
2022
Q1
$8.53M Hold
200,692
3.82% 12
2021
Q4
$8M Buy
200,692
+6,387
+3% +$248K 3.81% 12
2021
Q3
$7.02M Buy
194,305
+96,649
+99% +$3.76M 3.21% 12
2021
Q2
$4M Buy
+97,656
New +$4.15M 1.89% 17

Other funds holding RPRX

Geo Capital Gestora de Recursos's RPRX Position: Q3 2024 in Review

Geo Capital Gestora de Recursos sold out of Royalty Pharma (RPRX) in Q3 2024, closing a stake of 11,643 shares — an estimated $307K sold.

Geo Capital Gestora de Recursos first reported a position in RPRX in Q2 2021 and held it in 13 quarters. The position peaked at $8.53M in Q1 2022. 395 funds tracked by Wall St. Rank hold RPRX as of Q3 2024.

  • Geo Capital Gestora de Recursos reported no remaining Royalty Pharma position as of Q3 2024 after selling out during the quarter.
  • Geo Capital Gestora de Recursos sold 11,643 Royalty Pharma shares in Q3 2024, an estimated $307K.
  • Geo Capital Gestora de Recursos first reported a position in Royalty Pharma in Q2 2021 and held it in 13 quarters.
  • Geo Capital Gestora de Recursos's Royalty Pharma position peaked at $8.53M in Q1 2022.
  • 395 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2024.

Based on Geo Capital Gestora de Recursos's 13F filing for Q3 2024, filed 13 Nov 2024.